J.B. Chemicals & Pharmaceuticals Ltd. has announced that its Board of Directors has recommended a final dividend of Rs. 9.30 per equity share for the financial year 2025-26. This payout represents a 930% dividend on the face value of Re. 1 per share. The final approval for this dividend payment is subject to the confirmation by shareholders at the company’s upcoming Annual General Meeting.
Dividend Distribution Details
The Board of Directors of J.B. Chemicals & Pharmaceuticals Ltd. met on May 11, 2026, to review and approve the dividend proposal for the 2025-26 financial year. The company has recommended a final dividend of Rs. 9.30 per equity share, having a face value of Re. 1 each. This distribution is equivalent to a 930% dividend payout.
Shareholder Approval and Timeline
The proposed dividend is pending formal approval from the shareholders at the company’s ensuing Annual General Meeting. Once the dividend is declared and approved by the shareholders, the company is committed to remitting the payout to eligible investors within 30 days of the declaration date. Investors are advised to track the upcoming meeting schedule for further updates regarding the record date and payment distribution.
Source: BSE
